Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single-cell landscape of the mouse HNSCC-related bone invasive lesion

ABSTRACT: Single-cell landscape of the mouse HNSCC-related bone invasive lesion

PROVIDER: PRJNA1007698 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25721970_1.fastq.gz	Fastqsanger.gz
	SRR25721970_2.fastq.gz	Fastqsanger.gz
	SRR25721971_1.fastq.gz	Fastqsanger.gz
	SRR25721971_2.fastq.gz	Fastqsanger.gz
	SRR25721972_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Single-cell landscape of the mouse HNSCC-related bone invasive lesion

Project description:To understand the invasive microenvironment of head and neck squamous cell carcinomas (HNSCCs) at a single-cell resolution, we performed single-cell RNA-sequencing (scRNA-seq) using cells derived from calvaria of tumor-free control mice and tumor-excised calvarial tissues from pre-invasive stage（scratch-negative）and invasive stage（scratch-positive）groups 1 week after the implantation of C57BL/6-derived HNSCC cell line HNM007 cells.

2024-06-17 | GSE241334 | GEO

Gene expression signature of bone lesion waldenstrom macroglobulinemia and myeloma

Project description:Bone lesion in waldenstom macroglobulinemia (WM) is less common. In the present study, we compaired gene expresion signature of bone lesion in WM compaired to multiple myeloma (MM). In WM, APRIL and HBGB1 were up-regulated compaired to MM.

2020-07-06 | GSE70515 | GEO

ChIP–seq on periosteal cells derived from the pre-invasive group using antibodies to acetylated histone H3 Lys27 (H3K27ac), H3K4me3 and HIF-1α

Project description:To test whether HIF-1a can directly induce Timp1 expression in periosteal cells at the pre-invasive stage of head and neck squamous cell carcinoma (HNSCC), we performed Chromatin immunoprecipitation followed by sequencing (ChIP–seq) on periosteal cells derived from the pre-invasive stage of a mouse HNSCC bone invasion model by using antibodies to acetylated histone H3 Lys27 (H3K27ac), H3K4me3 and HIF-1α.

2024-06-17 | GSE256307 | GEO

Transcription profiling of human samples of multiple myeloma patients with and without bone lytic lesion by MRI

Project description:This series represents samples of multiple myeloma patients with and without bone lytic lesion by MRI.

2007-09-25 | E-GEOD-755 | biostudies-arrayexpress

Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing

Project description:Based on RNA-seq, we performed transcriptomic profiling to examine the differences between Orthotopic and IVBL (in vivo bone lesion). We found Calcium signalling is upregulated in IVBL and correlated to the expression of gap junctions.

2018-10-16 | GSE110451 | GEO

Profiling in vivo Bone Lesion and ex vivo Bone-In-Culture Array Samples by Next-Generation Sequencing

Project description:Based on RNA-seq, we performed transcriptomic profiling to examine the similarities or differences between BICA (bone-in-culture array) and IVBL (in vivo bone lesion). CIBERSORT analysis reveals that the major local cellular components are comparable between BICA and IVBL, but differ dramatically in orthotopic tumors. Principle component analysis of human RNAs indicated that the transcriptomic profiles of cancer cells in BICA are more closely mimicking IVBL, as compared to cancer cells in 2D and in orthotopic tumors. These results provide transcriptome-wide evidence supporting BICA as a platform to mimic bone microenvironment.

2017-01-20 | GSE84114 | GEO

MRI-lytic-lesion

Project description:This series represents samples of multiple myeloma patients with bone lytic lesion by MRI. Keywords = multiple myeloma Keywords = osteolytic lesions Keywords = MRI Keywords = osteoblast Keywords = mesenchymal stem cell Keywords = Wnt signaling Keywords = DKK1 Keywords: other

2004-01-01 | GSE754 | GEO

FER kinase governs invasive tumor growth through dynamic control of oncogenic growth factor receptor activity

Project description:EGFR antagonism using monoclonal antibodies remains the only approved and targeted first line treatment option for non-resectable head and neck squamous cell carcinoma (HNSCC), yielding a modest 13% response rate. While it is clear that alternative growth factor receptor (GFR) signals govern refractory behavior towards EGFR antagonism, it remains unknown which upstream mechanisms control subcellular GFR activation. Here, we show that FER, a non-receptor tyrosine kinase, controls invasive tumor growth through dynamic GFR activation and recycling. Using patient derived organoid (PDO) models HNSCC we demonstrate that FER is essential for invasive growth in collagen extracellular matrix (ECM) networks. We show that inactivation of FER impairs growth factor dependent phosphorylation of EGFR-Y1068 and MET-Y1234/5. Additionally, FER controls ligand dependent endocytic recycling, and endocytic velocity, implying multifactorial functional regulation of proximal receptors during HNSCC invasion. Loss of function experiments using either genetic intervention or a FER PROteolysis-TArgeting Chimera (PROTAC) strategy in PDO-based xenograft mouse models, demonstrate that FER is essential for invasive growth and metastasis of HNSCC. Finally, we demonstrate direct clinical relevance by showing that FER expression levels correlate with poor survival in HNSCC patients. In sum, we conclude that FER is a master regulator of HNSCC invasive growth and metastasis, and nominate FER as a prominent candidate for targeted clinical intervention in HNSCC patients.

2024-03-31 | GSE255878 | GEO

MRI-no-lytic-lesion

Project description:This series represents samples of multiple myeloma patients without bone lytic lesion by MRI. Keywords = multiple myeloma Keywords = osteolytic lesions Keywords = MRI Keywords = osteoblast Keywords = mesenchymal stem cell Keywords = Wnt signaling Keywords = DKK1 Keywords: other

2004-01-01 | GSE753 | GEO

Profiling in vivo Bone Lesion and ex vivo Bone-In-Culture Array Samples by Next-Generation Sequencing

Project description:Profiling in vivo Bone Lesion and ex vivo Bone-In-Culture Array Samples by Next-Generation Sequencing

| PRJNA328044 | ENA